What is 3B Blackbio Dx Ltd (3BBLACKBIO) share price return in the past 10 years?

3B Blackbio Dx Ltd share price has appreciated 60.7% annually (CAGR) over the past ten years.

What is the share price of 3B Blackbio Dx Ltd (3BBLACKBIO)?

Company share prices are keep on changing according to the market conditions. The current trading price of 3B Blackbio Dx Ltd (3BBLACKBIO) on 30-Sep-2026 13:58:00 at 13:58 is 1720.90.

What is the P/E ratio of 3B Blackbio Dx?

The latest standalone P/E ratio of 3B Blackbio Dx as of 30-Sep-2026 is 27.37.

What is the P/B ratio of 3B Blackbio Dx Ltd (3BBLACKBIO)?

The latest standalone P/B ratio of 3B Blackbio Dx Ltd (3BBLACKBIO) as of 30-Sep-2026 is 4.86.

What is the 52-week high and low of 3B Blackbio Dx Ltd (3BBLACKBIO)?

The 52-week high of 3B Blackbio Dx Ltd (3BBLACKBIO) is Rs. 1750.00 and the 52-week low is Rs. 1083.50.

3B Blackbio Dx Ltd (3BBLACKBIO)

Name: 3B Blackbio Dx Ltd (3BBLACKBIO)
Brand: 3B Blackbio Dx

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532067 NSE: 3BBLACKBIO Medical Equipment/Supplies/Accessories | Small Cap | 3B Blackbio Dx Share Price

₹1,720.90 95.80 (5.90%)

As on 30-Sep'26 13:58

3B Blackbio Dx Ltd (3BBLACKBIO)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532067 NSE: 3BBLACKBIO Medical Equipment/Supplies/Accessories | Small Cap | 3B Blackbio Dx Share Price

₹1,720.90 95.80 (5.90%)

As on 30-Sep'26 13:58

Key Metrics

Valuation Multiples

Market Cap

₹1,395 Cr.

Current Price

₹1,720.9

52-Week Low / High

₹1,084 / 1,750

TTM EPS

₹64.7

TTM Sales

₹153 Cr.

Book Value per Share

₹326.2

P/E Ratio

25.12

Lower than its 5-year historical median

Industry PE

126.3

Price to Book (P/B)

4.98

Lower than its 5-year historical median

Price to Sales (P/S)

9.11

Lower than its 5-year historical median

EV/EBITDA

16.05

Lower than its 5-year historical median

Dividend Yield

0.23%

Profitability Efficiency

Return on Equity (ROE)

20.22%

Outperforms industry median

Return on Capital Employed (ROCE)

25.90%

Outperforms industry median

Return on Assets (ROA)

17.79%

Operating Profit Margin

51.9%

Net Profit Margin

42.23%

Gross Profit Margin

57.9%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

28.01%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

13.29%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

25.67%

Asset Quality

Promoter Holding

40.95%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹271 Cr.

Equity

₹8.6 Cr.

Face Value

₹10

All Time Low / High

₹4.81 / 2350.00

3B Blackbio Dx stock performance

Key Ratios

Check Before You Invest

Quality

Very Good

Check detailed performance

Valuation

Fair

Check Valuation charts

Price Trend

Strong

Check Price chart

Q.1 Is 3B Blackbio Dx Ltd a good quality company?

3B Blackbio Dx Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does 3B Blackbio Dx Ltd performance compare with that of its Peers?

Q.1 Revenue growth of 3B Blackbio Dx Ltd vs industry peers?

3B Blackbio Dx Ltd revenue CAGR is 27.29%, compared to the industry median CAGR of 0.00%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of 3B Blackbio Dx Ltd?

Promoters hold 40.95% of the 3B Blackbio Dx Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of 3B Blackbio Dx Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 60% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	4.8%	5.5%	6.1%	4.2%	4.1%	9.5%	33.5%	10.8%	36.6%	25.5%	-
Value Creation Index ⓘ	-0.7	-0.6	-0.6	-0.7	-0.7	-0.3	1.4	-0.2	1.6	0.8	-
Growth Parameters ⓘ
Sales ⓘ	15.7	13	15.6	12.1	13.5	14.4	15.5	12	70.7	90.5	100
Sales YoY Gr.	-	-17.1%	19.6%	-22.3%	11.8%	6.3%	8.1%	-22.7%	489.3%	28%	-
Adj EPS ⓘ	0.3	0.4	0.8	0.7	0.8	2.3	10.7	2.9	39.8	55.3	59.4
YoY Gr.	-	24.1%	125%	-17.3%	22.4%	179.3%	365.9%	-73%	1283.3%	38.7%	-
BVPS (₹) ⓘ	17.3	17.3	17.6	24.6	27.7	30.2	31.9	32.3	265.8	318.4	334.3
Adj Net Profit ⓘ	0.2	0.2	0.5	0.4	0.6	1.7	8	2.2	34.2	47.4	51
Cash Flow from Ops. ⓘ	0.9	0.2	-0.8	0.5	1.1	2.8	8	1.7	28.5	44.5	-
Debt/CF from Ops. ⓘ	8.5	33.4	-7.6	13.7	3.2	0.7	0.3	1.2	0	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	21.5%	46.3%	80%	28%
Adj EPS ⓘ	79.2%	132.1%	73%	38.7%
BVPSⓘ	38.2%	62.9%	115.2%	19.8%
Share Price	60.7%	30.1%	29.9%	25.2%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	1.7	2.1	3.9	2.7	3.4	7.9	34.4	9	27.1	19	18.2
Op. Profit Mgn % ⓘ	6.6	8.2	7	3.6	-1.8	-8.4	-7.9	-7.8	49.6	55.1	54.9
Net Profit Mgn % ⓘ	1.2	1.8	3.3	3.6	4.5	12	51.6	18	48.4	52.4	51
Debt to Equity ⓘ	0.7	0.7	0.5	0.4	0.2	0.1	0.1	0.1	0	0	-
Working Cap Days ⓘ	445	529	488	665	597	549	521	686	214	246	233
Cash Conv. Cycle ⓘ	203	273	288	425	389	357	318	427	121	151	202

Valuation of 3B Blackbio Dx - Consolidated

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Sales	16	23	23	29	227	81	62	74	96	142
Operating Expenses ⓘ +	14	18	16	20	77	44	33	41	46	85
Manufacturing Costs	9	1	1	1	1	1	1	1	2	4
Material Costs	0	13	11	13	52	32	18	22	26	36
Employee Cost	2	2	3	3	1	2	4	4	4	20
Other Costs ⓘ	3	3	2	3	24	9	10	14	15	25
Operating Profit ⓘ	3	5	7	9	150	37	29	33	50	57
Operating Profit Margin (%)	15.9%	23.4%	31.0%	32.3%	66.1%	46.0%	47.1%	44.5%	51.9%	40.0%
Other Income ⓘ +	0	0	1	2	3	7	7	13	15	26
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	1	1	0	0	0	0	0	0	0	0
Depreciation ⓘ	0	0	1	1	1	1	1	1	1	5
Profit Before Tax ⓘ	1	5	7	10	152	43	35	44	64	77
Tax ⓘ	0	1	2	2	38	11	9	12	16	17
Profit After Tax	1	3	5	8	114	32	26	32	48	60
PAT Margin (%)	7.0%	14.8%	22.5%	26.6%	50.2%	39.9%	41.9%	43.3%	49.4%	42.2%
Adjusted EPS (₹)	1.8	5.4	8.2	10.3	152.0	43.0	30.3	37.5	55.7	69.9
Dividend Payout Ratio (%)	16.90%	9.30%	6.10%	6.80%	0.70%	24.40%	8.30%	8%	7.20%	7.20%

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Equity and Liabilities
Shareholders Fund +	11	14	22	32	132	153	193	223	268	324
Share Capital ⓘ	6.38	6.38	6.39	7.49	7.49	7.49	8.57	8.57	8.57	8.57
Reserves ⓘ	5	7	16	25	125	146	185	214	260	316
Debt +	9	6	6	4	2	3	2	1	0	3
Long Term Debt	3	2	2	1	1	1	1	1	0	3
Short Term Debt	6	3	4	2	1	2	1	0	0	0
Minority Interest	0	0	0	2	16	19	3	2	3	7
Trade Payables	4	3	4	3	3	4	3	4	2	7
Others Liabilities ⓘ	1	7	3	4	40	14	13	18	22	36
Total Liabilities ⓘ	26	30	36	45	194	192	214	248	296	378
Fixed Assets
Net Fixed Assets ⓘ +	3	4	4	4	5	7	8	7	7	28
Gross Block	7	8	8	9	11	12	14	14	15	36
Accumulated Depreciation	3	4	4	5	6	5	6	7	8	9
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0	0	0	1	59	93	92	117	156	158
Inventories	4	4	5	4	5	7	8	8	9	18
Trade Receivables	14	16	18	20	35	30	34	36	37	50
Cash Equivalents ⓘ	0	2	3	9	35	29	59	62	69	101
Others Assets ⓘ	4	5	5	6	55	26	13	17	18	24
Total Assets ⓘ	26	30	36	45	194	192	214	248	296	378

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Cash Flow From Operating Activity ⓘ +	1	2	4	7	98	37	20	27	43	52
PBT ⓘ	1	5	7	10	152	43	35	44	64	77
Adjustment ⓘ	1	1	1	1	1	1	-2	-5	-5	2
Changes in Working Capital ⓘ	-2	-3	-3	-1	-17	4	-5	-2	-1	-11
Tax Paid ⓘ	-0	-1	-2	-2	-38	-11	-9	-11	-15	-16
Cash Flow From Investing Activity ⓘ +	-0	-1	-1	-1	-70	-28	15	-20	-34	-24
Capex	-0	-1	-1	-1	-2	-2	-2	-1	-1	-26
Net Investments	0	0	0	0	-69	-34	4	-20	-33	-6
Others ⓘ	-0	0	0	-0	-0	8	13	0	-0	8
Cash Flow From Financing Activity ⓘ +	-0	0	-1	1	-2	-15	-5	-4	-3	-1
Net Proceeds from Shares ⓘ	0	0	0	1	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	-0	3
Interest Paid ⓘ	-1	-1	-0	-0	-0	-0	-0	-0	-0	-0
Dividend Paid ⓘ	-0	-1	-1	-2	0	-15	-4	-2	-3	-3
Others ⓘ	1	2	0	2	-1	0	-0	-1	-0	0
Net Cash Flow ⓘ	0	1	2	7	26	-6	30	3	6	28

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Ratios
ROE (%)	10.47	27.55	28.99	28.15	138.73	22.59	14.98	15.42	19.41	20.22
ROCE (%)	12.52	23.8	28.04	32.29	179.46	29.92	20.24	21.21	26.03	25.9
Asset Turnover Ratio	0.7	0.84	0.7	0.71	1.9	0.42	0.3	0.32	0.35	0.42
PAT to CFO Conversion(x)	1	0.67	0.8	0.88	0.86	1.16	0.77	0.84	0.9	0.87
Working Capital Days
Receivable Days	290.60	239.30	274.10	242.80	44	146.60	188.70	172.80	137.70	111.40
Inventory Days	76.60	59.80	67.90	57.30	7.20	27.90	45.70	40.60	32.50	34.90
Payable Days	0	113.30	124.70	100.60	22.40	37.50	70.40	61.20	42.10	45.30

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

3B Blackbio Dx Ltd FAQs

The current trading price of 3B Blackbio Dx on 30-Sep-2026 13:58 is ₹1,720.9.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 29-Sep-2026 the market cap of 3B Blackbio Dx stood at ₹1,394.8 Cr

The latest P/E ratio of 3B Blackbio Dx as of 29-Sep-2026 is 27.37.

The latest P/B ratio of 3B Blackbio Dx as of 29-Sep-2026 is 4.86.

The 52-week high of 3B Blackbio Dx is ₹1,750 and the 52-week low is ₹1,083.5.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of 3B Blackbio Dx is ₹99.86 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that 3B Blackbio Dx Ltd is a good quality company.

The key valuation ratios of 3B Blackbio Dx Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of 3B Blackbio Dx Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About 3B Blackbio Dx Ltd

Kilpest India is one of India's leading agri-based companies. Kilpest is an ISO certified company and has representation in India in the field of agriculture business comprising crop protection products and public health products, bio products, micro-nutrients and mix fertilizers. The company has one of the most advance Research & Development facility at its Bhopal plant and also has Biological Research Centre. The products are manufactured to high international! BlS specifications with stringent quality control from raw material procurement to finished goods despatch.

The products are manufactured to high international / BIS specifications with stringent quality control from raw material procurement to finished goods despatch. The company's manufacturing process is complimented with the technical expertise and it has attained high standard suited to customer needs.

The company has a nationwide distribution network. Kilpest is also doing toll formulations for multinational industries. Products of Kilpest are exported to several countries. The company is listed on the Bombay Stock Exchange. It is also registered with D&B, D-V-N-S.

Products range of the company includes:

Emulsifiable Concentrate
Wettable Powder/Soluble Powders
Garanules
Dusting Powder
Botanical Pesticides
Spray Adjuvant Cone
Flowering Stimulent / Yield Booster
Insecticide For Public Health
House Hold Insecticide
Sampada (Micro-Nutrients) / Fytozyme (Plant Growth Stimulant)

Clientele:

Directarate General of Supplies& Transport, New Delhi.
Directarate Health Services Haryana, Chandigarh.
Controller of Procurement, Material Organisation, Eastern Naval, Command, Visakhpatnam (NAVY).
Western Railway, Mumbai.
Central Railway, Mumbai.
Directorate of Central Medical Stores Organisation, Gujarat, Gandhi Nagar.
The Director General Medical Health and Family welfare, U. P. Lucknow.
Central Warehousing Corporation, Delhi.
Central Public Works Department, Kanpur & Bhopal.
Food Corporation of India, Bhopal, Lucknow, Mumbai, Jaipur.
Indian Farmers Fertilizer Co-operative Ltd. New Delhi.
M. P. State Co-operative Marketing Federation Ltd. Jehangirabad, Bhopal
Municipal Corporation, Bhopal/lndore, and many more

Achievements/ recognition:

An ISO certified company

You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

3B Blackbio Dx Ltd (3BBLACKBIO)

3B Blackbio Dx Ltd (3BBLACKBIO)

3B Blackbio Dx stock performance